ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
FDA Approved a Generic Version of Viagra- But Will Not be Available Until 2017
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Jasen Bruce" data-source="post: 34451" data-attributes="member: 14"><p>Sildenafil has also been available since 2005 in the form of Revatio 20mg tablet (also owned by Pfizer) and also as a compounded generic. Here is a summary of the current status of sildenafil, its availability, and how it is able to be compounded while the patent is still active for Viagra</p><p></p><p> If the drug is under patent then the compounder is not supposed to compound it, however there are some exceptions. Viagra was patented in 2002 and is still under protective patent until 2019 for use in treating erectile dysfunction. Although pharmacies are not supposed to compound generic Sildenafil, the raw material is still available for sale to US compounding pharmacies. This raw sildenafil powder comes from FDA approved suppliers. It is speculated that the compounding of sildenafil is not resisted/enforced against because of the fact it is compounded in such a large volume and the patent protection for Viagra is close to wearing off. At this point the patent for Viagra is a “lame duck”. A drug that remains under a ‘strong’ patent will usually result in the legal enforcement needed to prevent both compounds and branded generics from penetrating the market while the patent is active. This is their chance to rake in massive profit margins until the patent expires. On a side note, manufactures like Pfizer can pay to extend the patent- they will always assess profitability to determine if having the extension is worth the money paid to extend the patent. The makers of Viagra did not fight the patent for Revatio which is a 20mg Sildenafil indicated for pulmonary arterial hypertension instead of Erectile Dysfunction because Pfizer owns this drug too. Revatio was patented in 2005, the patent expired in 2012 opening the doors for many other generics to hit the market. New introduction of these new generic low dosed sildenadil is what you are seeing in the news. To provide a comparison of cost, the AWP for brand Viagra is $40. AWP for Revatio is $11 per tablet, and Compounded Sildenafil in any strength up to 110mg typically costs $5-$7 to the patient. The wholesale cost is far less than the AWP.</p></blockquote><p></p>
[QUOTE="Jasen Bruce, post: 34451, member: 14"] Sildenafil has also been available since 2005 in the form of Revatio 20mg tablet (also owned by Pfizer) and also as a compounded generic. Here is a summary of the current status of sildenafil, its availability, and how it is able to be compounded while the patent is still active for Viagra If the drug is under patent then the compounder is not supposed to compound it, however there are some exceptions. Viagra was patented in 2002 and is still under protective patent until 2019 for use in treating erectile dysfunction. Although pharmacies are not supposed to compound generic Sildenafil, the raw material is still available for sale to US compounding pharmacies. This raw sildenafil powder comes from FDA approved suppliers. It is speculated that the compounding of sildenafil is not resisted/enforced against because of the fact it is compounded in such a large volume and the patent protection for Viagra is close to wearing off. At this point the patent for Viagra is a “lame duck”. A drug that remains under a ‘strong’ patent will usually result in the legal enforcement needed to prevent both compounds and branded generics from penetrating the market while the patent is active. This is their chance to rake in massive profit margins until the patent expires. On a side note, manufactures like Pfizer can pay to extend the patent- they will always assess profitability to determine if having the extension is worth the money paid to extend the patent. The makers of Viagra did not fight the patent for Revatio which is a 20mg Sildenafil indicated for pulmonary arterial hypertension instead of Erectile Dysfunction because Pfizer owns this drug too. Revatio was patented in 2005, the patent expired in 2012 opening the doors for many other generics to hit the market. New introduction of these new generic low dosed sildenadil is what you are seeing in the news. To provide a comparison of cost, the AWP for brand Viagra is $40. AWP for Revatio is $11 per tablet, and Compounded Sildenafil in any strength up to 110mg typically costs $5-$7 to the patient. The wholesale cost is far less than the AWP. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
FDA Approved a Generic Version of Viagra- But Will Not be Available Until 2017
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top